In Billing
Feb 19th, 2018
Effective Jan. 1, 2018, newly approved biosimilar biologicals with a common reference product are no longer grouped into the same billing code. This change was finalized in the 2018 Medicare Physician Fee Schedule final rule. Q5102 Replaced with Two New Codes The April 2018 update to the Medicare Physician Fee Schedule Database (MPFSD) includes three ...
Sep 22nd, 2015
Effective Sept. 3, 2015, the status indicator for HCPCS Level II code Q5101 Injection, Filgrastim (G-CSF), Biosimilar, 1 microgram has changed from E Not paid by Medicare when submitted on outpatient claims (any outpatient bill type) to K Paid under OPPS; separate APC payment. This change is effective Oct. 1, 2015. The Centers for Medicare ...
Apr 2nd, 2015
The scheduled release of modifications to the HCPCS Level II code set are available on the Centers for Medicare & Medicaid Services’ HCPCS Quarterly Update web page. Here’s the list of C codes included in the April update. HCPCS Code Long Description Added Date Termination Date Comments C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion ca...